Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.

Arva NC, Talbott KE, Okoro DR, Brekman A, Qiu WG, Bargonetti J. Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes. Ethn Dis. 2008; 18(2 Suppl 2):S2-1-8.

View in: PubMed

subject areas

Antineoplastic Agents, Phytogenic
Cell Line, Tumor
Cloning, Molecular
DNA Damage
Etoposide
Flow Cytometry
Genotype
Humans
Imidazoles
Neoplasms
Phenotype
Piperazines
Polymorphism, Single Nucleotide
Proto-Oncogene Proteins c-mdm2
Reverse Transcriptase Polymerase Chain Reaction
Tumor Suppressor Protein p53

authors with profiles

Jill Bargonetti

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support